Status:
COMPLETED
Myo-inositol and Vitamin D3 During IVF
Lead Sponsor:
Lo.Li.Pharma s.r.l
Conditions:
Female Infertility
Eligibility:
FEMALE
18-42 years
Phase:
NA
Brief Summary
Administration of a multicomponent dietary supplement (myo-inositol, vitamin D3, folic acid and melatonin) to women undergoing IVF procedures. The aim of the study is to monitor the effects on the pr...
Eligibility Criteria
Inclusion
- BMI (kg/m2): 18.5 - 24.9
- basal FSH on day 3 \<15 mIU/ml
Exclusion
- presence of insulin resistance (IR)
- hyperglycaemia, hyperprolactinemia, hypothyroidism or androgen excess
- diagnosis of PCOS (according to Rotterdam ESHRE-ASRM Sponsored PCOS consensus workshop group)
- intake of hormones or drugs that can potentially influence the ovulation
- FSH\>15 on day 3
Key Trial Info
Start Date :
May 2 2018
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
May 31 2019
Estimated Enrollment :
120 Patients enrolled
Trial Details
Trial ID
NCT04019899
Start Date
May 2 2018
End Date
May 31 2019
Last Update
July 15 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Clinica Alma Res
Roma, RM, Italy, 00198